US 12,357,612 B2
Prophylactic or therapeutic agent for cancer
Takaaki Abe, Miyagi (JP); Shinobu Ohnuma, Miyagi (JP); Michiaki Unno, Miyagi (JP); and Kenichiro Hayashi, Okayama (JP)
Assigned to TOHOKU UNIVERSITY, Miyagi (JP); and KAKE EDUCATIONAL INSTITUTION, Okayama (JP)
Appl. No. 17/442,173
Filed by TOHOKU UNIVERSITY, Miyagi (JP); and KAKE EDUCATIONAL INSTITUTION, Okayama (JP)
PCT Filed Mar. 25, 2020, PCT No. PCT/JP2020/013411
§ 371(c)(1), (2) Date Sep. 23, 2021,
PCT Pub. No. WO2020/196651, PCT Pub. Date Oct. 1, 2020.
Claims priority of application No. 2019-063638 (JP), filed on Mar. 28, 2019.
Prior Publication US 2022/0175724 A1, Jun. 9, 2022
Int. Cl. A61K 31/405 (2006.01); A61K 9/00 (2006.01); A61P 35/00 (2006.01)
CPC A61K 31/405 (2013.01) [A61K 9/0053 (2013.01); A61P 35/00 (2018.01)] 4 Claims
 
1. A method for treating cancer, comprising administering one or more compounds selected from the compound of the following formula (1-1), the compound of the following formula (2-1):

OG Complex Work Unit Chemistry
or a pharmacologically acceptable salt thereof, to a subject in need of treatment of cancer.